Study of Brentuximab Vedotin in Patients With R/R PTCL Treated With Gemcitabine
Clinical trial NCT03496779 · COMPLETED
Trial details
- NCT number
- NCT03496779
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-10
- Primary completion
- 2020-01-31
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.